%0 Generic %A Gu, Shuyan %A Mu, Yiming %A Zhai, Suodi %A Zeng, Yuhang %A Zhen, Xuemei %A Dong, Hengjin %D 2016 %T Sensitivity analyses results for dapagliflozin arm versus acarbose arm (results per patient). %U https://plos.figshare.com/articles/dataset/Sensitivity_analyses_results_for_dapagliflozin_arm_versus_acarbose_arm_results_per_patient_/4203852 %R 10.1371/journal.pone.0165629.t009 %2 https://plos.figshare.com/ndownloader/files/6860712 %K healthcare payer perspective %K sensitivity analyses %K China Objective %K treatment-naive patients %K Sensitivity analyses %K Type 2 Diabetes %K 40 years %K disease burden %K treatment comparison %K dapagliflozin %K hospital surveys %K Systematic literature reviews %K cost-effectiveness %K comparator therapies %K type 2 diabetes mellitus %K QALY gain %K mortality events %K Cardiff Diabetes Model %K T 2DM %K model-required patient profiles %K Conclusion Dapagliflozin %K alternative medication %K Chinese T 2DM patients %K acarbose %K disease progression %K monotherapy %X

Sensitivity analyses results for dapagliflozin arm versus acarbose arm (results per patient).

%I PLOS ONE